Still unclear which patients with ovarian cancer will benefit from adjuvant chemotherapy after surgery

摘要

Adjuvant chemotherapy given immediately after surgery for early-stage ovarian cancer improves both overall and recurrence-free survival for some patients,results from two European studies suggest.However,in an editorialpublished in the Founal of the National Cancer Institute,Dr Robert Young of the Fox Chase cancer centre,Philadelphia,says that thetrials do not address which patients can be spared unnecessary adjuvant chemotherapy and calls for further studies.